September 2nd, 2021 · Common Contracts · 1000 similar ShiftPixy, Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of August __, 2021, between ShiftPixy, Inc., a Wyoming corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of August __, 2021, between ShiftPixy, Inc., a Wyoming corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
November 9th, 2015 · Common Contracts · 1000 similar NephroGenex, Inc. – REGISTRATION RIGHTS AGREEMENT This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).
March 25th, 2020 · Common Contracts · 1000 similar Evofem Biosciences, Inc. – RIGHTS AGREEMENT RIGHTS AGREEMENT, dated as of March 24, 2020 (the “Agreement”), between Evofem Biosciences, Inc., a Delaware corporation (the “Company”), and Philadelphia Stock Transfer, Inc., as rights agent (the “Rights Agent”). WHEREAS, effective...
April 22nd, 2022 · Common Contracts · 1000 similar Monterey Capital Acquisition Corp – MONTEREY CAPITAL ACQUISITION CORPORATION UNDERWRITING AGREEMENT Monterey Capital Acquisition Corporation, a Delaware corporation (the “Company”), hereby confirms its agreement with EF Hutton, division of Benchmark Investments LLC (the “Representative”), as representative of the several underwriters named on Schedule A hereto (the “Underwriters” or, each underwriter individually, an “Underwriter”), as follows:
Monterey Capital Acquisition Corporation, a Delaware corporation (the “Company”), hereby confirms its agreement with EF Hutton, division of Benchmark Investments LLC (the “Representative”), as representative of the several underwriters named on Schedule A hereto (the “Underwriters” or, each underwriter individually, an “Underwriter”), as follows:
February 23rd, 2021 · Common Contracts · 990 similar Myriad Genetics Inc – AMENDMENT NO. 3 dated as of February 22, 2021 to CREDIT AGREEMENT Dated as of December 23, 2016 THIS AMENDMENT NO. 3 (“Amendment”), dated as of February 22, 2021 (the “Effective Date”), is entered into by and among MYRIAD GENETICS, INC., a Delaware corporation (the “Borrower”), the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent (the “Administrative Agent”). Each capitalized term used herein and not defined herein shall have the meaning ascribed thereto in the Credit Agreement, dated as of December 23, 2016 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among the Borrower, the Lenders from time to time party thereto, and the Administrative Agent.
THIS AMENDMENT NO. 3 (“Amendment”), dated as of February 22, 2021 (the “Effective Date”), is entered into by and among MYRIAD GENETICS, INC., a Delaware corporation (the “Borrower”), the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent (the “Administrative Agent”). Each capitalized term used herein and not defined herein shall have the meaning ascribed thereto in the Credit Agreement, dated as of December 23, 2016 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among the Borrower, the Lenders from time to time party thereto, and the Administrative Agent.
September 23rd, 2021 · Common Contracts · 914 similar Synlogic, Inc. – SYNLOGIC, INC. (a Delaware corporation) 15,000,000 Shares of Common Stock UNDERWRITING AGREEMENT
May 24th, 2022 · Common Contracts · 876 similar Embrace Change Acquisition Corp. – EMBRACE CHANGE ACQUISITION CORP. UNDERWRITING AGREEMENT Embrace Change Acquisition Corp., a Cayman Islands exempted company (the “Company”), hereby confirms its agreement with EF Hutton, division of Benchmark Investments, LLC (the “Representative”), as representative of the several underwriters named on Schedule A hereto (the “Underwriters” or, each underwriter individually, an “Underwriter”), as follows:
Embrace Change Acquisition Corp., a Cayman Islands exempted company (the “Company”), hereby confirms its agreement with EF Hutton, division of Benchmark Investments, LLC (the “Representative”), as representative of the several underwriters named on Schedule A hereto (the “Underwriters” or, each underwriter individually, an “Underwriter”), as follows:
March 1st, 2011 · Common Contracts · 846 similar International Surf Resorts, Inc. – REGISTRATION RIGHTS AGREEMENT
February 4th, 2022 · Common Contracts · 791 similar Dermata Therapeutics, Inc. – DERMATA THERAPEUTICS, INC. UNDERWRITING AGREEMENT The undersigned, Dermata Therapeutics, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
The undersigned, Dermata Therapeutics, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
March 5th, 1998 · Common Contracts · 786 similar Applied Science & Technology Inc – and
April 30th, 2014 · Common Contracts · 686 similar Gi Dynamics, Inc. – INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 20 between GI Dynamics, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 20 between GI Dynamics, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
June 21st, 2021 · Common Contracts · 627 similar Novan, Inc. – NOVAN, INC. 3,636,364 Shares of Common Stock (par value $0.0001 per share) Underwriting Agreement
January 20th, 2021 · Common Contracts · 617 similar Environmental Impact Acquisition Corp – FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of January 13, 2021 by and between Environmental Impact Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
This Investment Management Trust Agreement (this “Agreement”) is made effective as of January 13, 2021 by and between Environmental Impact Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
January 5th, 2022 · Common Contracts · 599 similar Intra-Cellular Therapies, Inc. – INTRA-CELLULAR THERAPIES, INC. 10,952,381 Shares of Common Stock (Including 1,428,571 Option Shares) Underwriting Agreement Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 9,523,810 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,428,571 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 9,523,810 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,428,571 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
August 14th, 2019 · Common Contracts · 532 similar MICT, Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of [_____], 2019, between MICT, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of [_____], 2019, between MICT, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
March 22nd, 1999 · Common Contracts · 523 similar Dominos Pizza Government Services Division Inc – INDENTURE
March 29th, 1996 · Common Contracts · 449 similar Immunogen Inc – EXHIBIT A-2 to Securities Purchase Agreement REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of March 15, 1996 by and among IMMUNOGEN, INC., a Massachusetts corporation, with headquarters located at 128 Sidney...
May 26th, 2020 · Common Contracts · 426 similar Viela Bio, Inc. – Viela Bio, Inc. Common Stock Underwriting Agreement Viela Bio, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as Representatives, an aggregate of [•] shares (the “Firm Shares”) of common stock, par value $0.001 per share (“Stock”), of the Company. In addition, the stockholders of the Company named in Schedule II hereto (the “Selling Stockholders”) propose, subject to the terms and conditions stated in this Agreement, to sell, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of Stock (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
Viela Bio, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as Representatives, an aggregate of [•] shares (the “Firm Shares”) of common stock, par value $0.001 per share (“Stock”), of the Company. In addition, the stockholders of the Company named in Schedule II hereto (the “Selling Stockholders”) propose, subject to the terms and conditions stated in this Agreement, to sell, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of Stock (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
January 11th, 2016 · Common Contracts · 419 similar Acceleron Pharma Inc – 3,750,000 SHARES ACCELERON PHARMA INC. COMMON STOCK ($0.001 PAR VALUE) UNDERWRITING AGREEMENT January 5, 2016
November 8th, 2006 · Common Contracts · 380 similar VIASPACE Inc. – REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 2, 2006, by and between VIASPACE INC., a Nevada corporation (the “Company”), and CORNELL CAPITAL PARTNERS, LP, a Delaware limited partnership (the “Investor”).
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 2, 2006, by and between VIASPACE INC., a Nevada corporation (the “Company”), and CORNELL CAPITAL PARTNERS, LP, a Delaware limited partnership (the “Investor”).
February 16th, 2021 · Common Contracts · 374 similar Caladrius Biosciences, Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 12, 2021, between Caladrius Biosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of February 12, 2021, between Caladrius Biosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
May 22nd, 2020 · Common Contracts · 374 similar Westwater Resources, Inc. – REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of May 21, 2020, by and between WESTWATER RESOURCES, INC., a Delaware corporation (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of May 21, 2020, by and between WESTWATER RESOURCES, INC., a Delaware corporation (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
May 5th, 2022 · Common Contracts · 370 similar Modular Medical, Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of May 2, 2022, between Modular Medical, Inc., a company incorporated under the laws of Nevada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of May 2, 2022, between Modular Medical, Inc., a company incorporated under the laws of Nevada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
September 28th, 2007 · Common Contracts · 362 similar Ideation Acquisition Corp. – WARRANT AGREEMENT THIS WARRANT AGREEMENT (this “Agreement”), dated as of ___, 2007, is entered into by and between Ideation Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Warrant Agent”).
THIS WARRANT AGREEMENT (this “Agreement”), dated as of ___, 2007, is entered into by and between Ideation Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Warrant Agent”).
June 1st, 2017 · Common Contracts · 341 similar Inpixon – SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of the 31st day of May, 2017, by and between Inpixon, a Nevada corporation (f/k/a Sysorex Global, a Nevada corporation) (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of the 31st day of May, 2017, by and between Inpixon, a Nevada corporation (f/k/a Sysorex Global, a Nevada corporation) (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
March 15th, 2019 · Common Contracts · 338 similar Corindus Vascular Robotics, Inc. – Corindus Vascular Robotics, Inc. 8-K THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
October 27th, 2020 · Common Contracts · 337 similar Turning Point Therapeutics, Inc. – Turning Point Therapeutics, Inc. Common Stock Underwriting Agreement Turning Point Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 4,597,702 shares of the Company’s common stock, par value $0.0001 per share (“Stock”, and such shares, the “Firm Shares”) and, at the election of the Underwriters, up to 689,655 additional shares (the “Optional Shares”) of Stock. The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Shares”.
Turning Point Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 4,597,702 shares of the Company’s common stock, par value $0.0001 per share (“Stock”, and such shares, the “Firm Shares”) and, at the election of the Underwriters, up to 689,655 additional shares (the “Optional Shares”) of Stock. The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Shares”.
April 1st, 2022 · Common Contracts · 317 similar Forte Biosciences, Inc. – Forte Biosciences, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement Forte Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Agent”) as follows:
Forte Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Agent”) as follows:
March 4th, 2019 · Common Contracts · 300 similar Mersana Therapeutics, Inc. – MERSANA THERAPEUTICS, INC. 21,250,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement Mersana Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 21,250,000 shares of common stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 3,187,500 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
Mersana Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 21,250,000 shares of common stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 3,187,500 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
March 19th, 2018 · Common Contracts · 290 similar Corindus Vascular Robotics, Inc. – LOAN AND SECURITY AGREEMENT (REVOLVING LINE) THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of March 16, 2018 (the “Effective Date”) by and among (a) SILICON VALLEY BANK, a California corporation (“Bank”), and (b) (i) CORINDUS VASCULAR ROBOTICS, INC., a Delaware corporation (“Parent Borrower”) and (ii) CORINDUS, INC., a Delaware corporation (“Subsidiary Borrower”) (Parent Borrower and Subsidiary Borrower are individually and collectively, jointly and severally, “Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of March 16, 2018 (the “Effective Date”) by and among (a) SILICON VALLEY BANK, a California corporation (“Bank”), and (b) (i) CORINDUS VASCULAR ROBOTICS, INC., a Delaware corporation (“Parent Borrower”) and (ii) CORINDUS, INC., a Delaware corporation (“Subsidiary Borrower”) (Parent Borrower and Subsidiary Borrower are individually and collectively, jointly and severally, “Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:
November 8th, 2006 · Common Contracts · 288 similar VIASPACE Inc. – SECURITY AGREEMENT THIS SECURITY AGREEMENT (the “Agreement”), is entered into and made effective as of November 2, 2006, by and between VIASPACE INC., a Nevada corporation with its principal place of business located at 171 N. Altadena Drive, Suite 101, Pasadena, CA 91107 (the “Company”), and the BUYER(S) (the “Secured Party”) listed on Schedule I attached to the Securities Purchase Agreement (the “Securities Purchase Agreement”) dated the date hereof between the Company and the Secured Party.
THIS SECURITY AGREEMENT (the “Agreement”), is entered into and made effective as of November 2, 2006, by and between VIASPACE INC., a Nevada corporation with its principal place of business located at 171 N. Altadena Drive, Suite 101, Pasadena, CA 91107 (the “Company”), and the BUYER(S) (the “Secured Party”) listed on Schedule I attached to the Securities Purchase Agreement (the “Securities Purchase Agreement”) dated the date hereof between the Company and the Secured Party.
November 8th, 2006 · Common Contracts · 286 similar VIASPACE Inc. – SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 2, 2006, by and among VIASPACE INC., a Nevada corporation (the “Company”), and the Buyers listed on Schedule I attached hereto (individually, a “Buyer” or collectively “Buyers”).
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 2, 2006, by and among VIASPACE INC., a Nevada corporation (the “Company”), and the Buyers listed on Schedule I attached hereto (individually, a “Buyer” or collectively “Buyers”).
July 1st, 2005 · Common Contracts · 264 similar Coley Pharmaceutical Group, Inc. – COLEY PHARMACEUTICAL GROUP, INC. (a Delaware corporation) [ ] Shares of Common Stock PURCHASE AGREEMENT
December 14th, 2021 · Common Contracts · 253 similar Eyenovia, Inc. – EYENOVIA, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENT
November 8th, 2006 · Common Contracts · 252 similar VIASPACE Inc. – INVESTOR REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 2, 2006, by and among VIASPACE INC., a Nevada corporation (the “Company”), and the undersigned investors listed on Schedule I attached hereto (each, an “Investor” and collectively, the “Investors”).
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 2, 2006, by and among VIASPACE INC., a Nevada corporation (the “Company”), and the undersigned investors listed on Schedule I attached hereto (each, an “Investor” and collectively, the “Investors”).